{"id":"https://openalex.org/W4393095423","doi":"https://doi.org/10.1158/1538-7445.am2024-4622","title":"Abstract 4622: Anti-tumor activity of CDK2 inhibitor BLU-222 in combination with CDK4/6 inhibitors for overcoming resistance in HR positive and triple negative metastatic breast cancers models","display_name":"Abstract 4622: Anti-tumor activity of CDK2 inhibitor BLU-222 in combination with CDK4/6 inhibitors for overcoming resistance in HR positive and triple negative metastatic breast cancers models","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393095423","doi":"https://doi.org/10.1158/1538-7445.am2024-4622"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4622","doi":"https://doi.org/10.1158/1538-7445.am2024-4622","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-4622","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016125750","display_name":"Linjie Luo","orcid":"https://orcid.org/0000-0002-2365-0327","observed_orcids":["https://orcid.org/0000-0002-2365-0327"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linjie Luo","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100322740","display_name":"Yan Wang","orcid":"https://orcid.org/0000-0002-6122-9437","observed_orcids":["https://orcid.org/0000-0002-6122-9437"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yan Wang","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000113218","display_name":"Tuyen N. Bui","orcid":"https://orcid.org/0000-0001-8509-3653","observed_orcids":["https://orcid.org/0000-0001-8509-3653"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tuyen Bui","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100453890","display_name":"Mi Li","orcid":"https://orcid.org/0000-0002-6038-4144","observed_orcids":["https://orcid.org/0000-0002-6038-4144"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mi Li","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Serena Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Serena Kim","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017644527","display_name":"Juliana Navarro-Yepes","orcid":"https://orcid.org/0000-0003-0393-3773","observed_orcids":["https://orcid.org/0000-0003-0393-3773"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliana Navarro-Yepes","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026936750","display_name":"Nicole M. Kettner","orcid":"https://orcid.org/0000-0003-2043-4407","observed_orcids":["https://orcid.org/0000-0003-2043-4407"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicole M. Kettner","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debasish Tripathy","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017411324","display_name":"Kelly K. Hunt","orcid":"https://orcid.org/0000-0001-9156-8723","observed_orcids":["https://orcid.org/0000-0001-9156-8723"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly K. Hunt","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kerrie Faia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100156","display_name":"Blueprint Medicines (United States)","ror":"https://ror.org/0142eak56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100156"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerrie Faia","raw_affiliation_strings":["2Blueprint Medicines Corporation, Cambridge, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Blueprint Medicines Corporation, Cambridge, MA","institution_ids":["https://openalex.org/I4210100156"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042960706","display_name":"Khandan Keyomarsi","orcid":"https://orcid.org/0000-0002-5440-0849","observed_orcids":["https://orcid.org/0000-0002-5440-0849"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khandan Keyomarsi","raw_affiliation_strings":["1UT MD Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UT MD Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4622","last_page":"4622"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk2-inhibitors","display_name":"CDK2 inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9089999794960022},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.9419999718666077},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7049999833106995},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8199999928474426},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6679999828338623},{"id":"https://openalex.org/keywords/synergistic-effect","display_name":"synergistic effect","score":0.6660000085830688},{"id":"https://openalex.org/keywords/cyclin-e","display_name":"cyclin E","score":0.7429999709129333},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8550000190734863},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.6669999957084656},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5709999799728394},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8460000157356262},{"id":"https://openalex.org/keywords/transgenic-mouse-model","display_name":"transgenic mouse model","score":0.640999972820282},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6155397891998291},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5530399680137634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43312498927116394},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.371871680021286}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4622","doi":"https://doi.org/10.1158/1538-7445.am2024-4622","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-4622","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7125398609","https://openalex.org/W4396597269","https://openalex.org/W4322774964","https://openalex.org/W4416947827","https://openalex.org/W4322771199","https://openalex.org/W4409821394","https://openalex.org/W4399323938","https://openalex.org/W2400518997","https://openalex.org/W3106785508","https://openalex.org/W2610265777"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Cyclin-dependent-kinase-4/6":[2],"inhibitors":[3,434],"(CDK4/6is)":[4],"plus":[5,33,172],"endocrine":[6],"therapy":[7],"(ET)":[8],"are":[9],"standard":[10],"of":[11,29,45,76,89,130,147,189,213,267,299,320,332,340,354,383,392,395,426,451],"care":[12],"first-line":[13],"treatment":[14,41,285,288,391],"for":[15,389,435,455],"patients":[16,48,166],"with":[17,39,49,60,84,136,153,243,289,294,361,387,432],"hormone":[18],"receptor":[19],"(HR)-positive,":[20],"HER2-negative":[21],"metastatic":[22,444],"breast":[23,52,94,112,181,198,368,396,445],"cancer":[24,53,95,113,182,199,369],"(mBC).":[25],"However,":[26],"the":[27,57,71,128,139,257,265,297,317,329,337,346,355,379,390,452],"emergence":[28],"resistance":[30,437],"to":[31,97,203,209,276,313],"CDK4/6is":[32,46,85,362,388],"ET":[34],"presents":[35],"a":[36,78,179,223],"clinical":[37,381],"challenge":[38],"few":[40],"alternatives.":[42],"The":[43,145,193,211],"effectiveness":[44,146],"in":[47,86,122,134,138,143,151,158,217,227,237,251,270,303,305,324,344,363,373,385,430,438],"triple-negative":[50],"(TN)":[51],"remains":[54],"uncertain,":[55],"although":[56],"potential":[58,380],"synergy":[59],"other":[61],"targeted":[62],"therapies":[63],"is":[64],"currently":[65],"under":[66],"investigation.":[67],"Our":[68],"study":[69],"demonstrates":[70],"enhanced":[72,231],"and":[73,92,105,107,110,133,178,196,215,233,245,256,280,334,342,366,372,441],"synergistic":[74,225,330],"activity":[75,250,331,353,425],"BLU-222,":[77,148,290],"selective":[79],"CDK2":[80,356,427],"inhibitor,":[81,357],"when":[82,359],"combined":[83,293,360],"preclinical":[87],"models":[88,163,255,447],"both":[90,393],"HR+/HER2-":[91,103,165,195,365],"TN":[93,108,175,180,197,261,367],"resistant":[96,101,364],"CDK4/6is.":[98],"Methods:":[99],"Palbociclib":[100],"(PR)":[102],"(MCF7":[104],"T47D)":[106],"(MDA-MB-231":[109],"BT-20)":[111],"cell":[114,200,220,234,370],"lines":[115,221,371],"were":[116],"generated":[117],"by":[118,186],"escalating":[119],"palbociclib":[120,137,171,216,246],"concentrations":[121],"culture.":[123],"Using":[124],"SynergyFinder,":[125],"we":[126,309],"assessed":[127],"effect":[129,226],"BLU-222":[131,214,244,333,358,384,429],"alone":[132,149,291],"combination":[135,152,212,274,386,431],"highest":[140],"single-agent":[141],"model":[142,184],"vitro.":[144],"or":[150,239,292,322],"palbociclib,":[154,204,295,335],"was":[155],"further":[156],"evaluated":[157],"four":[159,219],"patient-derived":[160],"xenograft":[161],"(PDX)":[162],"from":[164],"whose":[167],"tumors":[168,312],"progressed":[169],"after":[170,284],"ET,":[173],"two":[174],"PDX":[176,254],"models,":[177,263,307],"transgenic":[183,262],"driven":[185],"tumor-specific":[187],"forms":[188],"cyclin":[190,258],"E.":[191],"Results:":[192],"PR":[194,228,326],"lines,":[201],"unresponsive":[202],"exhibited":[205],"significantly":[206],"increased":[207],"sensitivity":[208],"BLU-222.":[210],"all":[218,252,304],"revealed":[222],"robust":[224,352],"cells,":[229],"inducing":[230],"apoptosis":[232],"cycle":[235],"alterations":[236],"G1":[238],"G2/M":[240],"phases.":[241],"Treatment":[242],"demonstrated":[247],"substantial":[248],"antitumor":[249],"six":[253],"E":[259],"high":[260],"surpassing":[264],"effects":[266],"individual":[268],"treatments":[269],"each":[271],"model.":[272],"This":[273],"led":[275],"lasting":[277],"tumor":[278],"regression":[279],"extended":[281],"survival,":[282],"even":[283],"discontinuation.":[286],"Mechanistically,":[287],"induced":[296],"expression":[298],"p21":[300,321,341],"and/or":[301],"p27":[302,323,343],"vivo":[306,374],"which":[308],"hypothesize":[310],"sensitizes":[311],"palbociclib.":[314],"In":[315],"vitro,":[316],"CRISPR":[318],"knockout":[319],"MCF-7":[325],"cells":[327],"abolished":[328],"confirming":[336],"crucial":[338],"involvement":[339],"influencing":[345],"treatment's":[347],"effectiveness.":[348],"Conclusions:":[349],"We":[350],"found":[351],"models.":[375],"These":[376],"results":[377],"support":[378],"utility":[382],"subtypes":[394],"cancer.":[397],"Citation":[398],"Format:":[399],"Linjie":[400],"Luo,":[401],"Yan":[402],"Wang,":[403],"Tuyen":[404],"Bui,":[405],"Mi":[406],"Li,":[407],"Serena":[408],"Kim,":[409],"Juliana":[410],"Navarro-Yepes,":[411],"Nicole":[412],"M.":[413],"Kettner,":[414],"Debasish":[415],"Tripathy,":[416],"Kelly":[417],"K.":[418],"Hunt,":[419],"Kerrie":[420],"Faia,":[421],"Khandan":[422],"Keyomarsi.":[423],"Anti-tumor":[424],"inhibitor":[428],"CDK4/6":[433],"overcoming":[436],"HR":[439],"positive":[440],"triple":[442],"negative":[443],"cancers":[446],"[abstract].":[448],"In:":[449],"Proceedings":[450],"American":[453],"Association":[454],"Cancer":[456,474],"Research":[457],"Annual":[458],"Meeting":[459],"2024;":[460],"Part":[461],"1":[462],"(Regular":[463],"Abstracts);":[464],"2024":[465],"Apr":[466],"5-10;":[467],"San":[468],"Diego,":[469],"CA.":[470],"Philadelphia":[471],"(PA):":[472],"AACR;":[473],"Res":[475],"2024;84(6_Suppl):Abstract":[476],"nr":[477],"4622.":[478]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-15T10:00:46.086208","created_date":"2024-03-23T00:00:00"}